Date
28 September 2023
Unlocking Access: Major Pharma Companies’ Initiatives in LMICs Under the Spotlight
Bizwatch in Kenya covers the release of the Foundation's first report from its Generics & Biosimilar Medicines Programme, consisting of in-depth profiles of five major manufacturers.
Direct links
The article notes that this is the firt time that generic manufacturers - in this case Cipla, Hikma, Sun Pharma, Teva and Viatris - have had an in-depth assessment on their efforts to expand access to their products in low- and middle-income countries.
The Foundation's CEO, Jayasree Iyer, is quoted: "Companies must engage with the unmet medical need globally – for example, by working with local manufacturers to improve supply, by taking steps to safeguard quality, by making their essential products available in more countries, and by addressing affordability for the poorest patients.”
Read the Foundation's report on generic and biosimilar medicine manufacturers.